First Header Logo Second Header Logo

Connection

Steven Feldman to Interleukin-23 Subunit p19

Back to Details
This is a "connection" page, showing publications Steven Feldman has written about Interleukin-23 Subunit p19.
Steven Feldman
Connection Strength
1.336
Interleukin-23 Subunit p19
  1. Li W, Ghamrawi R, Haidari W, Feldman SR. Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis. Ann Pharmacother. 2020 04; 54(4):380-387.
    View in: PubMed
    Score: 0.692
  2. Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
    View in: PubMed
    Score: 0.644
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.